Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1992-8-28
|
pubmed:abstractText |
Although previous studies have shown that the tumor necrosis factor-alpha (TNF) gene is expressed in pregnancy decidua, it has not been determined whether this gene is transcribed or translated in the endometrium prior to implantation. To address this question and to identify cells expressing the TNF gene, samples of normal cycling human endometria were tested for TNF mRNA by in situ hybridization using a biotinylated antisense RNA probe, and the corresponding protein was localized in the same tissues by immunocytochemistry with a monoclonal antibody to TNF. Both TNF message and protein were identified in the endometrium throughout the menstrual cycle, and the same types of cells that contained transcripts also contained protein. As judged by the intensities of the hybridization signals, TNF mRNA increased during the proliferative phases, declined in the early secretory phase, and again rose during mid-to-late secretory phases, suggesting positive associations with levels of female sex hormones that show similar cyclic fluctuations. At the initiation of the cycle, transcripts were primarily localized to glandular epithelial cells whereas by the midproliferative phase, message was also present in stromal cells. Hybridization signals were consistently more intense in functionalis-region than in basalis-region stromal cells, and were frequently stronger in basalis-region glandular epithelia than in functionalis-region glands. These observations document that the TNF gene is expressed in normal cycling endometria, suggest that ovarian hormones may regulate TNF gene transcription, and identify differences in specific endometrial compartments. The findings are also consistent with the postulate that TNF is a local mediator of cellular communications in the human endometrium.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0006-3363
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
47
|
pubmed:geneSymbol |
TNF
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
141-7
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:1637942-Adult,
pubmed-meshheading:1637942-Antibodies, Monoclonal,
pubmed-meshheading:1637942-Cell Communication,
pubmed-meshheading:1637942-DNA,
pubmed-meshheading:1637942-Endometrium,
pubmed-meshheading:1637942-Epithelial Cells,
pubmed-meshheading:1637942-Epithelium,
pubmed-meshheading:1637942-Female,
pubmed-meshheading:1637942-Gene Expression,
pubmed-meshheading:1637942-Humans,
pubmed-meshheading:1637942-Immunohistochemistry,
pubmed-meshheading:1637942-Middle Aged,
pubmed-meshheading:1637942-Nucleic Acid Hybridization,
pubmed-meshheading:1637942-RNA, Messenger,
pubmed-meshheading:1637942-Transcription, Genetic,
pubmed-meshheading:1637942-Tumor Necrosis Factor-alpha
|
pubmed:year |
1992
|
pubmed:articleTitle |
Tumor necrosis factor-alpha messenger ribonucleic acid and protein in human endometrium.
|
pubmed:affiliation |
Department of Pathology and Oncology, University of Kansas Medical Center, Kansas City 66103.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|